Immunovia AB (publ)

BATS-CHIXE:IMMNOS Stock Report

Market Cap: SEK 551.8m

Immunovia Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IMMNOS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders6,183,66527.3%
Institutions6,574,19929%
General Public9,873,71743.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 55.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.56%
Carl Arne Borrebaeck
1,709,900SEK 41.7m0%no data
6.36%
Alandsbanken Asset Management Limited
1,439,415SEK 35.1m0%7.04%
6.12%
Avanza Fonder AB
1,384,980SEK 33.8m0%0.08%
5.06%
Ranny Davidoff
1,144,936SEK 27.9m271%no data
3.75%
Per Ohlin
848,950SEK 20.7m0%no data
3.75%
Sara Andersson Ek
848,907SEK 20.7m0%no data
3.31%
Christer Wingren
748,525SEK 18.2m0%no data
2.83%
Credit Suisse Asset Management (Switzerland)
640,784SEK 15.6m0%no data
2.78%
Vincent Saldell
628,830SEK 15.3m0%no data
2.57%
Coeli Wealth Management AB
580,518SEK 14.2m0%64.46%
2.52%
Royal Bank of Canada, Banking & Securities Investments
571,432SEK 13.9m0%no data
2.07%
Handelsbanken Asset Management
467,788SEK 11.4m0%no data
1.82%
Nordnet AB (publ), Asset Management Arm
411,309SEK 10.0m0%0.15%
1.27%
United Securities AB
287,688SEK 7.0m0%0.65%
1.06%
Coeli Asset Management
239,881SEK 5.8m0%0.32%
0.96%
Xact Kapitalförvaltning AB
216,857SEK 5.3m0%no data
0.44%
AP Fonden 2
99,067SEK 2.4m0%no data
0.28%
SEB Investment Management AB
62,461SEK 1.5m-10.1%no data
0.27%
Northern Light Management AB
61,776SEK 1.5m0%1.23%
0.23%
Patrik Dahlen
51,860SEK 1.3m0%no data
0.22%
Rolf Ehrnstrom
50,750SEK 1.2m0%no data
0.22%
Banor Capital Ltd.
50,000SEK 1.2m0%0.04%
0.16%
Christofer Sjögren
37,332SEK 910.2k0%no data
0.14%
Linda Mellby
32,626SEK 795.4k0%no data
0.14%
Hans Johansson
31,242SEK 761.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/01/28 17:18
End of Day Share Price 2022/10/31 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Immunovia AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lars HevrengDanske Bank
Juan Pedro Rodríguez SerrateEdison Investment Research
Alexandru CogutKempen & Co. NV